Author:
Møgelvang Josefine,Pezeshki Parmida Sadat
Publisher
Springer International Publishing
Reference11 articles.
1. Bonafé L, Hästbacka J, de la Chapelle A, Campos-Xavier AB, Chiesa C, Forlino A, Superti-Furga A, Rossi A (2008) A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. J Med Genet 45(12):827–831. https://doi.org/10.1136/jmg.2007.057158. Epub 2008 Aug 15
2. Fallon MJ, Hockey A, Hallam LA (1994) Atelosteogenesis type III: a case report. Pediatr Radiol 24(1):47–49. https://doi.org/10.1007/BF02017661
3. Farrington-Rock C, Firestein MH, Bicknell LS, Superti-Furga A, Bacino CA, Cormier-Daire V, Le Merrer M, Baumann C, Roume J, Rump P, Verheij JBGM, Sweeney E, Rimoin DL, Lachman RS, Robertson SP, Cohn DH, Krakow D (2006) Mutations in two regions of FLNB result in atelosteogenesis I and III. Hum Mutat 27:705–710. https://doi.org/10.1002/humu.20348
4. Hästbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES (1996) Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet 58(2):255–262
5. Jeon GW, Lee MN, Jung JM, Hong SY, Kim YN, Sin JB, Ki CS (2014) Identification of a de novo heterozygous missense FLNB mutation in lethal atelosteogenesis type I by exome sequencing. Ann. Lab Med 34(2):134–138. https://doi.org/10.3343/alm.2014.34.2.134. Epub 2014 Feb 13